Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Condition:   Influenza InfectionInterventions:   Biological: GSK2340274A;   Biological: GSK2340273ASponsors:   GlaxoSmithKline;   GlaxoSmithKlineCompleted - verified January 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials